← Back to Search

D2S Intervention for HIV (D2S Trial)

N/A

Waitlist Available

Led By Denis Nash, PhD

Research Sponsored by City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will help researchers understand how to better help low-income people with HIV achieve viral suppression, which is key to reducing HIV health disparities and scaling up evidence-based interventions.

Who is the study for?

This trial is for low-income individuals in New York City with HIV who are already receiving care but have not achieved viral suppression. They must have had at least one viral load test showing unsuppressed levels and be enrolled in eligible Ryan White HIV/AIDS Program services.

What is being tested?

The study tests a 'data-to-suppression' (D2S) strategy aimed at improving viral suppression among patients using behavioral health and housing support programs within the Ryan White HIV/AIDS Program, by providing targeted interventions based on surveillance data.

What are the potential side effects?

Since this intervention involves data management and personalized support rather than medication, traditional side effects associated with drugs are not applicable. However, there may be privacy concerns or stress related to increased monitoring.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Timely viral suppression

Secondary study objectives

Time to viral suppression

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Early ImplementationExperimental Treatment1 Intervention

This arm will receive D2S intervention components during Period 1 (Early Implementation) as well as throughout Period 2 of the stepped-wedge trial.

Group II: Delayed ImplementationActive Control1 Intervention

This arm will receive no D2S intervention components during Period 1 (Early Implementation), but will then receive all D2S intervention components in Period 2, starting 12 months later.

Do I qualify?Apply below to find out